Literature DB >> 4039883

Thallium perfusion and cardiac enzyme abnormalities in patients with familial hypertrophic cardiomyopathy.

S Nagata, Y Park, T Minamikawa, C Yutani, T Kamiya, T Nishimura, T Kozuka, H Sakakibara, Y Nimura.   

Abstract

Twelve patients of five families with familial hypertrophic cardiomyopathy were examined. Within each family, the older patients showed dilation or diminished contraction of the left ventricle by echocardiography or angiocardiography more frequently than did younger patients. LDH1 fraction (lactic dehydrogenase isoenzyme) and MB-CPK (creatinine phosphokinase isoenzyme) were increased in 7 of 10 patients. Thallium-201 myocardial scintigraphy showed perfusion defect or hypoperfusion in 9 of 10 patient. Eleven cases demonstrated remarkable hypertrophy at the macroscopic level. Marked fibrosis was observed in all 5 of the 11 patients whose histologic findings were obtained. In two necropsy cases, disarray was found throughout the right and left ventricles and the pattern of fibrosis was massive. These findings were different from those of ordinary hypertrophic cardiomyopathy. It is possible that each patient with familial hypertrophic cardiomyopathy may develop more prominent thallium and enzyme abnormalities as he becomes older, regardless of whether he develops a dilated cardiomyopathy picture.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039883     DOI: 10.1016/0002-8703(85)90358-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation.

Authors:  Felix Y j Keng; Su Min Chang; Eduardo Cwajg; Zuo-Xiang He; Nasser M Lakkis; Sherif F Nagueh; William H Spencer; Mario S Verani
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

Review 2.  Nuclear cardiac imaging in hypertrophic cardiomyopathy.

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

3.  Effect of regional myocardial perfusion abnormalities on regional myocardial early diastolic function in patients with hypertrophic cardiomyopathy.

Authors:  H Yamanari; M Kakishita; Y Fujimoto; K Hashimoto; T Kiyooka; Y Katayama; F Otsuka; T Emori; S Uchida; T Ohe
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

4.  Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene.

Authors:  K Yamauchi-Takihara; C Nakajima-Taniguchi; H Matsui; Y Fujio; K Kunisada; S Nagata; T Kishimoto
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

5.  Clinical results with beta-methyl-p-(123I)iodophenylpentadecanoic acid, single-photon emission computed tomography in cardiac disease.

Authors:  T Nishimura; T Uehara; T Shimonagata; S Nagata; K Haze
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

6.  Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.

Authors:  T Nishimura; S Nagata; T Uehara; T Morozumi; Y Ishida; T Nakata; O Iimura; C Kurata; Y Wakabayashi; H Sugihara; K Otsuki; T Wada; Y Koga
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

7.  Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy.

Authors:  M Shimizu; N Sugihara; Y Kita; K Shimizu; Y Horita; K Nakajima; J Taki; R Takeda
Journal:  Br Heart J       Date:  1992-02

8.  Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  James M Wilson; Rollo P Villareal; Ramesh Hariharan; Ali Massumi; Raja Muthupillai; Scott D Flamm
Journal:  Tex Heart Inst J       Date:  2002

9.  Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy.

Authors:  S D Pringle; F G Dunn; A C Tweddel; W Martin; P W Macfarlane; J H McKillop; A R Lorimer; S M Cobbe
Journal:  Br Heart J       Date:  1992-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.